A method for evaluating the efficacy of a candidate drug for the treatment of a bipolar disorder is provided. The method includes administering the candidate drug or combination of drugs to a mouse characterized by an elevated amount of Otx2 protein in the hindbrain and evaluating the extent, frequency and/or reversal of a mouse behaviour that is homologous to a bipolar disorder in a human.
